1. Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome. Issue 170 (October 2018) Authors: Efthymiou, M.; Arachchillage, D.R.J.; Lane, P.J.; O'Keeffe, A.G.; McDonnell, T.; Cohen, H.; Mackie, I.J. Journal: Thrombosis research Issue: Issue 170(2018) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. (3rd October 2014) Authors: Arachchillage, D. R. J.; Efthymiou, M.; Mackie, I. J.; Lawrie, A. S.; Machin, S. J.; Cohen, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 11(2014:Nov.) Page Start: 1801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Can we ease the financial burden of colonoscopy? Using real‐time endoscopic assessment of polyp histology to predict surveillance intervals. Issue 12 (December 2015) Authors: Chandran, S.; Parker, F.; Lontos, S.; Vaughan, R.; Efthymiou, M. Journal: Internal medicine journal Issue: Volume 45:Issue 12(2015) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Current practice and research directions in hydrodynamics for FLNG-side-by-side offloading. (15th June 2018) Authors: Zhao, W.; Milne, I.A.; Efthymiou, M.; Wolgamot, H.A.; Draper, S.; Taylor, P.H.; Eatock Taylor, R. Journal: Ocean engineering Issue: Volume 158(2018) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Determination of APTT factor sensitivity – the misguiding guideline. Issue 6 (30th May 2013) Authors: Lawrie, A. S.; Kitchen, S.; Efthymiou, M.; Mackie, I. J.; Machin, S. J. Journal: International journal of laboratory hematology Issue: Volume 35:Issue 6(2013:Dec.) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. (9th May 2015) Authors: Arachchillage, D. R. J.; Mackie, I. J.; Efthymiou, M.; Isenberg, D. A.; Machin, S. J.; Cohen, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 7(2015:Jul.) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. (9th May 2015) Authors: Arachchillage, D. R. J.; Mackie, I. J.; Efthymiou, M.; Isenberg, D. A.; Machin, S. J.; Cohen, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 7(2015:Jul.) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism. Issue 2 (February 2015) Authors: Arachchillage, D.R.J.; Efthymiou, M.; Mackie, I.J.; Lawrie, A.S.; Machin, S.J.; Cohen, H. Journal: Thrombosis research Issue: Volume 135:Issue 2(2015) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism. Issue 2 (February 2015) Authors: Arachchillage, D.R.J.; Efthymiou, M.; Mackie, I.J.; Lawrie, A.S.; Machin, S.J.; Cohen, H. Journal: Thrombosis research Issue: Volume 135:Issue 2(2015) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism. (30th September 2016) Authors: Arachchillage, D. R. J.; Mackie, I. J.; Efthymiou, M.; Chitolie, A.; Hunt, B. J.; Isenberg, D. A.; Khamashta, M.; Machin, S. J.; Cohen, H. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 11(2016:Nov.) Page Start: 2177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗